Market Research Logo

Peanut Allergy - Pipeline Review, H2 2015

Peanut Allergy - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H2 2015’, provides an overview of the Peanut Allergy’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Peanut Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peanut Allergy and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Peanut Allergy
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Peanut Allergy and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Peanut Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Peanut Allergy pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Peanut Allergy
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Peanut Allergy pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Peanut Allergy Overview
Therapeutics Development
Pipeline Products for Peanut Allergy - Overview
Pipeline Products for Peanut Allergy - Comparative Analysis
Peanut Allergy - Therapeutics under Development by Companies
Peanut Allergy - Therapeutics under Investigation by Universities/Institutes
Peanut Allergy - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Peanut Allergy - Products under Development by Companies
Peanut Allergy - Products under Investigation by Universities/Institutes
Peanut Allergy - Companies Involved in Therapeutics Development
BioLingus AG
BioTech Tools s.a.
DBV Technologies S.A.
HAL Allergy BV
Immunomic Therapeutics, Inc.
Peanut Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
aldesleukin - Drug Profile Product Description
Mechanism of Action
R&D Progress
Allergen for Peanut Allergy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Allergen for Peanut Allergy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AR-101 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ARA-LAMP-Vax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DBV-712 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DN-1017 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drugs to Inhibit CYP11A1 for Peanut Allergy and Asthma - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drugs to Inhibit PIM-1 Kinase for Respiratory and Immunological Diseases - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PER-1080 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
pnut-ASIT - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Recombinant Protein for Peanut Allergy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Recombinant Vector Vaccine for Peanut Allergy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VTC-064 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Peanut Allergy - Recent Pipeline Updates
Peanut Allergy - Dormant Projects
Peanut Allergy - Discontinued Products
Peanut Allergy - Product Development Milestones
Featured News & Press Releases
Nov 11, 2015: Aimmune Therapeutics Reports Positive Findings for ARC002 Follow-On Phase 2 Study of AR101 for Treatment of Peanut Allergy
Oct 07, 2015: Aimmune Therapeutics Receives EMA Decision Agreeing With PIP for AR101 for the Treatment of Peanut Allergy
Oct 05, 2015: Follow-Up Study of Viaskin Peanut Shows Significant Increase in Peanut Consumption and Treatment Benefit in Peanut Allergic Children
Jun 22, 2015: DBV Technologies Confirms Planned Initiation of Viaskin Peanut Global Phase III Clinical Trial in Children Following End-of-Phase II Meeting with FDA and PIP approval by EMA
Jun 18, 2015: Aimmune Therapeutics Receives FDA Breakthrough Therapy Designation for AR101
Jun 08, 2015: DBV Technologies Presents Clinical and Scientific Data at the EAACI Congress
Jun 07, 2015: Aimmune Therapeutics Announces Positive Phase 2 Study Results of AR101 for the Treatment of Peanut Allergy
Jun 04, 2015: DBV Technologies Announces EMA Pediatric Committee positive opinion on the Pediatric Investigation Plan for Viaskin Peanut for the Treatment of Peanut Allergic Children
Jun 03, 2015: Aimmune Therapeutics to Announce Phase 2 Data at EAACI Congress 2015 for Study of Peanut Allergy Desensitization Treatment
May 13, 2015: Immunomic Therapeutics Awarded $1.2M Department of Defense Grant for Development of ARA-LAMP-vax Peanut Allergy Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Peanut Allergy, H2 2015
Number of Products under Development for Peanut Allergy - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Peanut Allergy - Pipeline by BioLingus AG, H2 2015
Peanut Allergy - Pipeline by BioTech Tools s.a., H2 2015
Peanut Allergy - Pipeline by DBV Technologies S.A., H2 2015
Peanut Allergy - Pipeline by HAL Allergy BV, H2 2015
Peanut Allergy - Pipeline by Immunomic Therapeutics, Inc., H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Peanut Allergy Therapeutics - Recent Pipeline Updates, H2 2015
Peanut Allergy - Dormant Projects, H2 2015
Peanut Allergy - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Peanut Allergy, H2 2015
Number of Products under Development for Peanut Allergy - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Targets, H2 2015
Number of Products by Stage and Targets, H2 2015
Number of Products by Mechanism of Actions, H2 2015
Number of Products by Stage and Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report